Offer - Urjas Oil for just ₹ 1 X
Cefazid 250 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Skin Infections, Pneumonia. The alternative uses of Cefazid 250 Injection have also been explained below.
The correct dosage of Cefazid 250 Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Cefazid 250 Injection side effects, there are can be others also. These have been listed below. Normally, these side effects of Cefazid 250 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Cefazid 250 Injection's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Cefazid 250 Injection related warnings talks about Cefazid 250 Injection's effects on the liver, heart and kidney.
Cefazid 250 Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease as it can result in adverse effects. Other conditions have been mentioned below in the Cefazid 250 Injection contraindications section.
Besides this, Cefazid 250 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Cefazid 250 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Cefazid 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Cefazid 250 Injection safe for pregnant women?
Cefazid is safe for pregnant women.
Is the use of Cefazid 250 Injection safe during breastfeeding?
Breastfeeding women can safely use Cefazid.
What is the effect of Cefazid 250 Injection on the Kidneys?
Cefazid has very mild side effects on the kidneys.
What is the effect of Cefazid 250 Injection on the Liver?
Using Cefazid does not have any harmful effects on the liver.
What is the effect of Cefazid 250 Injection on the Heart?
Cefazid is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Cefazid 250 Injection unless your doctor advises you to do so -
Is this Cefazid 250 Injection habit forming or addictive?
Forming a habit of Cefazid 250 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cefazid 250 Injection, you should not drive or work on any heavy machine, as Cefazid 250 Injection can make you drowsy.
Is it safe?
Yes, Cefazid 250 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Cefazid 250 Injection is not used to treat mental disorders.
Interaction between Food and Cefazid 250 Injection
Taking Cefazid 250 Injection with food does not harm your health.
Interaction between Alcohol and Cefazid 250 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Cefazid 250 Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312